Clinical Trial Update: Levosimendan Efficacy for Veno-arterial ECMO Weaning: a Retrospective Study

View source ↗

Summary

A retrospective study evaluating whether levosimendan facilitates weaning from veno-arterial ECMO in patients with cardiogenic shock.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiogenic Shock

Drugs mentioned

• Simdax (levosimendan)

Snippet

Sponsor: University Hospital, Strasbourg, France | Conditions: Cardiogenic Shock | Status: UNKNOWN